EPO Patents = 1

Forward Citations = 22

Loading Chart...

2 inventors (with patents filed for the assignee):

Ross Bersot (4 out of 6 patents)

Paul Humphries (4 out of 7 patents)

4 patents: Sort by Forward Citations

1. 10214507 - Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators (2019-02-26),

2. 10005759 - Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators (2018-06-26),

3. 9775845 - Carbazole-containing sulfonamides as cryptochrome modulators (2017-10-03),

4. 9265772 - Carbazole-containing sulfonamides as cryptochrome modulators (2016-02-23),

Reset Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for metabolic diseases. Their innovative approach targets biological pathways to reset circadian rhythms, improve metabolic function, and ultimately deliver transformative treatments for patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#819 in San Jose, CA

#13,684 in California

#59,078 in US

San Jose, CA, United States of America

Reset Therapeutics, Inc.

Forward Citations = 22

2 inventors:

Ross Bersot (4 out of 6 patents)

Paul Humphries (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com